Alex Zhavoronkov (born Aleksandrs Zavoronkovs)[3] is a Latvian-born scientist and author working in biotechnology, regenerative medicine, and aging economics.

Zhavoronkov has published a substantial number of papers, and books including The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy.

[9][10] Born in Latvia,[1][2][6] Zhavoronkov received two bachelor's degrees from Queen's University,[3] and worked in graphics processing before moving to the biotechnology field.

[14][15] In 2014, Zhavoronkov began work towards using "massive data sets and Al to significantly speed up the drug discovery process",[16] and established Insilico at Johns Hopkins University in Baltimore.

[1] In February 2023, Wesley J. Smith, writing for National Review, sharply criticized comments by Zhavoronkov, who had observed that organ transplants used to facilitate life extension could someday be provided by using human clones generated without cognitive functions.